Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient.
Canterbury Health Laboratories, Christchurch, New Zealand julie.creighton@cdhb.health.nz.
Julie
J
Creighton
Antibiotic Reference Laboratory, Institute for Environmental Science and Research (ESR), Wellington, New Zealand.
Helen
H
Heffernan
Canterbury Health Laboratories, Christchurch, New Zealand.
Julia
J
Howard
D000151:Acinetobacter Infections / Q000188:drug therapy / Q000382:microbiology; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D001426:Bacterial Proteins / Q000096:biosynthesis* / Q000378:metabolism; D024881:Drug Resistance, Bacterial; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D009520:New Zealand; D011512:Proteus Infections / Q000188:drug therapy / Q000382:microbiology; D011513:Proteus mirabilis / Q000187:drug effects* / Q000302:isolation & purification; D011532:Providencia / Q000187:drug effects* / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000378:metabolism*
D001426:Bacterial Proteins; C491478:beta-lactamase KPC-2; D001618:beta-Lactamases; C552864:beta-lactamase NDM-1; C063912:carbapenemase; C108449:oxacillinase